nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0165	0.0177	CcSEcCtD
Nefazodone—Rhabdomyolysis—Telbivudine—hepatitis B	0.0144	0.0154	CcSEcCtD
Nefazodone—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.0142	0.0152	CcSEcCtD
Nefazodone—Suicide—Lamivudine—hepatitis B	0.0138	0.0148	CcSEcCtD
Nefazodone—Neck pain—Telbivudine—hepatitis B	0.0129	0.0138	CcSEcCtD
Nefazodone—Suicide attempt—Lamivudine—hepatitis B	0.0126	0.0136	CcSEcCtD
Nefazodone—Hepatic failure—Entecavir—hepatitis B	0.0125	0.0134	CcSEcCtD
Nefazodone—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.0122	0.0131	CcSEcCtD
Nefazodone—Completed suicide—Lamivudine—hepatitis B	0.0122	0.0131	CcSEcCtD
Nefazodone—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.0101	0.0109	CcSEcCtD
Nefazodone—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00968	0.0104	CcSEcCtD
Nefazodone—Hyperaesthesia—Lamivudine—hepatitis B	0.00914	0.00981	CcSEcCtD
Nefazodone—Migraine—Telbivudine—hepatitis B	0.00909	0.00976	CcSEcCtD
Nefazodone—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00858	0.00921	CcSEcCtD
Nefazodone—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00832	0.00893	CcSEcCtD
Nefazodone—Cramp muscle—Telbivudine—hepatitis B	0.00832	0.00893	CcSEcCtD
Nefazodone—Haematuria—Entecavir—hepatitis B	0.00826	0.00887	CcSEcCtD
Nefazodone—Gastritis—Telbivudine—hepatitis B	0.00818	0.00877	CcSEcCtD
Nefazodone—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00815	0.00874	CcSEcCtD
Nefazodone—Rhabdomyolysis—Lamivudine—hepatitis B	0.00811	0.0087	CcSEcCtD
Nefazodone—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00806	0.00865	CcSEcCtD
Nefazodone—Abdominal distension—Telbivudine—hepatitis B	0.00804	0.00863	CcSEcCtD
Nefazodone—Influenza—Telbivudine—hepatitis B	0.00799	0.00857	CcSEcCtD
Nefazodone—Rectal haemorrhage—Lamivudine—hepatitis B	0.00794	0.00852	CcSEcCtD
Nefazodone—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00793	0.00851	CcSEcCtD
Nefazodone—Hepatitis—Entecavir—hepatitis B	0.00778	0.00835	CcSEcCtD
Nefazodone—Oedema peripheral—Entecavir—hepatitis B	0.00766	0.00822	CcSEcCtD
Nefazodone—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00759	0.00815	CcSEcCtD
Nefazodone—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00758	0.00814	CcSEcCtD
Nefazodone—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00753	0.00808	CcSEcCtD
Nefazodone—Muscle twitching—Lamivudine—hepatitis B	0.0073	0.00784	CcSEcCtD
Nefazodone—Eructation—Lamivudine—hepatitis B	0.00705	0.00756	CcSEcCtD
Nefazodone—Alopecia—Entecavir—hepatitis B	0.00688	0.00738	CcSEcCtD
Nefazodone—Photophobia—Lamivudine—hepatitis B	0.00673	0.00723	CcSEcCtD
Nefazodone—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00651	0.00699	CcSEcCtD
Nefazodone—Urine output increased—Lamivudine—hepatitis B	0.00649	0.00696	CcSEcCtD
Nefazodone—Mouth ulceration—Lamivudine—hepatitis B	0.00649	0.00696	CcSEcCtD
Nefazodone—Gynaecomastia—Lamivudine—hepatitis B	0.00642	0.00689	CcSEcCtD
Nefazodone—Back pain—Adefovir Dipivoxil—hepatitis B	0.00639	0.00686	CcSEcCtD
Nefazodone—Hepatitis—Telbivudine—hepatitis B	0.00639	0.00686	CcSEcCtD
Nefazodone—Hypoaesthesia—Telbivudine—hepatitis B	0.00636	0.00682	CcSEcCtD
Nefazodone—Pharyngitis—Telbivudine—hepatitis B	0.00634	0.00681	CcSEcCtD
Nefazodone—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00611	0.00655	CcSEcCtD
Nefazodone—Lymphadenopathy—Lamivudine—hepatitis B	0.0061	0.00655	CcSEcCtD
Nefazodone—Leukopenia—Entecavir—hepatitis B	0.00606	0.00651	CcSEcCtD
Nefazodone—Polyuria—Lamivudine—hepatitis B	0.00593	0.00636	CcSEcCtD
Nefazodone—Gastroenteritis—Lamivudine—hepatitis B	0.00587	0.0063	CcSEcCtD
Nefazodone—Deafness—Lamivudine—hepatitis B	0.00582	0.00625	CcSEcCtD
Nefazodone—Cough—Adefovir Dipivoxil—hepatitis B	0.00577	0.00619	CcSEcCtD
Nefazodone—Injury—Lamivudine—hepatitis B	0.00566	0.00608	CcSEcCtD
Nefazodone—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00563	0.00604	CcSEcCtD
Nefazodone—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00563	0.00604	CcSEcCtD
Nefazodone—Anaphylactic shock—Entecavir—hepatitis B	0.00553	0.00593	CcSEcCtD
Nefazodone—Infection—Entecavir—hepatitis B	0.00549	0.00589	CcSEcCtD
Nefazodone—Thirst—Lamivudine—hepatitis B	0.00547	0.00587	CcSEcCtD
Nefazodone—Dysgeusia—Telbivudine—hepatitis B	0.00545	0.00585	CcSEcCtD
Nefazodone—Back pain—Telbivudine—hepatitis B	0.00538	0.00577	CcSEcCtD
Nefazodone—Muscle spasms—Telbivudine—hepatitis B	0.00535	0.00574	CcSEcCtD
Nefazodone—Hypoglycaemia—Lamivudine—hepatitis B	0.00534	0.00572	CcSEcCtD
Nefazodone—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00528	0.00567	CcSEcCtD
Nefazodone—Ill-defined disorder—Telbivudine—hepatitis B	0.00516	0.00554	CcSEcCtD
Nefazodone—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00514	0.00552	CcSEcCtD
Nefazodone—Affect lability—Lamivudine—hepatitis B	0.00513	0.0055	CcSEcCtD
Nefazodone—Migraine—Lamivudine—hepatitis B	0.00513	0.0055	CcSEcCtD
Nefazodone—Malaise—Telbivudine—hepatitis B	0.00502	0.00538	CcSEcCtD
Nefazodone—Insomnia—Entecavir—hepatitis B	0.005	0.00536	CcSEcCtD
Nefazodone—Mood swings—Lamivudine—hepatitis B	0.00493	0.00529	CcSEcCtD
Nefazodone—Somnolence—Entecavir—hepatitis B	0.00491	0.00527	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00491	0.00527	CcSEcCtD
Nefazodone—Dyspepsia—Entecavir—hepatitis B	0.00487	0.00522	CcSEcCtD
Nefazodone—Cough—Telbivudine—hepatitis B	0.00486	0.00521	CcSEcCtD
Nefazodone—Dehydration—Lamivudine—hepatitis B	0.00484	0.0052	CcSEcCtD
Nefazodone—Liver function test abnormal—Lamivudine—hepatitis B	0.00481	0.00516	CcSEcCtD
Nefazodone—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00475	0.00509	CcSEcCtD
Nefazodone—Myalgia—Telbivudine—hepatitis B	0.00474	0.00508	CcSEcCtD
Nefazodone—Chest pain—Telbivudine—hepatitis B	0.00474	0.00508	CcSEcCtD
Nefazodone—Arthralgia—Telbivudine—hepatitis B	0.00474	0.00508	CcSEcCtD
Nefazodone—Cramp muscle—Lamivudine—hepatitis B	0.00469	0.00503	CcSEcCtD
Nefazodone—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00469	0.00503	CcSEcCtD
Nefazodone—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00469	0.00503	CcSEcCtD
Nefazodone—Discomfort—Telbivudine—hepatitis B	0.00468	0.00502	CcSEcCtD
Nefazodone—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00459	0.00493	CcSEcCtD
Nefazodone—Abdominal distension—Lamivudine—hepatitis B	0.00453	0.00486	CcSEcCtD
Nefazodone—Gastrointestinal pain—Entecavir—hepatitis B	0.00452	0.00485	CcSEcCtD
Nefazodone—Influenza—Lamivudine—hepatitis B	0.0045	0.00483	CcSEcCtD
Nefazodone—Dysphagia—Lamivudine—hepatitis B	0.0045	0.00483	CcSEcCtD
Nefazodone—Thrombocytopenia—Telbivudine—hepatitis B	0.00445	0.00477	CcSEcCtD
Nefazodone—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00441	0.00473	CcSEcCtD
Nefazodone—Abdominal pain—Entecavir—hepatitis B	0.00437	0.00469	CcSEcCtD
Nefazodone—Body temperature increased—Entecavir—hepatitis B	0.00437	0.00469	CcSEcCtD
Nefazodone—Bronchitis—Lamivudine—hepatitis B	0.00433	0.00464	CcSEcCtD
Nefazodone—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00426	0.00457	CcSEcCtD
Nefazodone—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00426	0.00457	CcSEcCtD
Nefazodone—Dysuria—Lamivudine—hepatitis B	0.00421	0.00452	CcSEcCtD
Nefazodone—Pollakiuria—Lamivudine—hepatitis B	0.00416	0.00446	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00414	0.00444	CcSEcCtD
Nefazodone—Insomnia—Telbivudine—hepatitis B	0.00411	0.00441	CcSEcCtD
Nefazodone—Paraesthesia—Telbivudine—hepatitis B	0.00408	0.00438	CcSEcCtD
Nefazodone—Dyspepsia—Telbivudine—hepatitis B	0.004	0.00429	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00398	0.00427	CcSEcCtD
Nefazodone—Asthenia—Entecavir—hepatitis B	0.00397	0.00426	CcSEcCtD
Nefazodone—Stomatitis—Lamivudine—hepatitis B	0.00391	0.0042	CcSEcCtD
Nefazodone—Pain—Telbivudine—hepatitis B	0.00388	0.00417	CcSEcCtD
Nefazodone—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00387	0.00415	CcSEcCtD
Nefazodone—Sweating—Lamivudine—hepatitis B	0.00385	0.00413	CcSEcCtD
Nefazodone—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00382	0.00409	CcSEcCtD
Nefazodone—Epistaxis—Lamivudine—hepatitis B	0.00378	0.00406	CcSEcCtD
Nefazodone—Diarrhoea—Entecavir—hepatitis B	0.00378	0.00406	CcSEcCtD
Nefazodone—Sinusitis—Lamivudine—hepatitis B	0.00376	0.00404	CcSEcCtD
Nefazodone—Feeling abnormal—Telbivudine—hepatitis B	0.00374	0.00402	CcSEcCtD
Nefazodone—Gastrointestinal pain—Telbivudine—hepatitis B	0.00371	0.00398	CcSEcCtD
Nefazodone—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00369	0.00396	CcSEcCtD
Nefazodone—Dizziness—Entecavir—hepatitis B	0.00366	0.00392	CcSEcCtD
Nefazodone—Rhinitis—Lamivudine—hepatitis B	0.00361	0.00387	CcSEcCtD
Nefazodone—Hepatitis—Lamivudine—hepatitis B	0.0036	0.00386	CcSEcCtD
Nefazodone—Abdominal pain—Telbivudine—hepatitis B	0.00359	0.00385	CcSEcCtD
Nefazodone—Body temperature increased—Telbivudine—hepatitis B	0.00359	0.00385	CcSEcCtD
Nefazodone—Hypoaesthesia—Lamivudine—hepatitis B	0.00358	0.00385	CcSEcCtD
Nefazodone—Pharyngitis—Lamivudine—hepatitis B	0.00358	0.00384	CcSEcCtD
Nefazodone—Vomiting—Entecavir—hepatitis B	0.00351	0.00377	CcSEcCtD
Nefazodone—Rash—Entecavir—hepatitis B	0.00349	0.00374	CcSEcCtD
Nefazodone—Dermatitis—Entecavir—hepatitis B	0.00348	0.00374	CcSEcCtD
Nefazodone—Headache—Entecavir—hepatitis B	0.00346	0.00372	CcSEcCtD
Nefazodone—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00343	0.00368	CcSEcCtD
Nefazodone—Erythema multiforme—Lamivudine—hepatitis B	0.00341	0.00365	CcSEcCtD
Nefazodone—Rash—Adefovir Dipivoxil—hepatitis B	0.0034	0.00365	CcSEcCtD
Nefazodone—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.0034	0.00365	CcSEcCtD
Nefazodone—Headache—Adefovir Dipivoxil—hepatitis B	0.00338	0.00363	CcSEcCtD
Nefazodone—Nausea—Entecavir—hepatitis B	0.00328	0.00352	CcSEcCtD
Nefazodone—Asthenia—Telbivudine—hepatitis B	0.00326	0.0035	CcSEcCtD
Nefazodone—Chills—Lamivudine—hepatitis B	0.00323	0.00347	CcSEcCtD
Nefazodone—Pruritus—Telbivudine—hepatitis B	0.00321	0.00345	CcSEcCtD
Nefazodone—Nausea—Adefovir Dipivoxil—hepatitis B	0.0032	0.00344	CcSEcCtD
Nefazodone—Alopecia—Lamivudine—hepatitis B	0.00318	0.00342	CcSEcCtD
Nefazodone—SLC6A4—blood plasma—hepatitis B	0.00316	0.114	CbGeAlD
Nefazodone—Diarrhoea—Telbivudine—hepatitis B	0.00311	0.00333	CcSEcCtD
Nefazodone—Flatulence—Lamivudine—hepatitis B	0.00309	0.00332	CcSEcCtD
Nefazodone—Dysgeusia—Lamivudine—hepatitis B	0.00307	0.00329	CcSEcCtD
Nefazodone—Back pain—Lamivudine—hepatitis B	0.00303	0.00325	CcSEcCtD
Nefazodone—Muscle spasms—Lamivudine—hepatitis B	0.00301	0.00323	CcSEcCtD
Nefazodone—Dizziness—Telbivudine—hepatitis B	0.003	0.00322	CcSEcCtD
Nefazodone—Tremor—Lamivudine—hepatitis B	0.00294	0.00315	CcSEcCtD
Nefazodone—Ill-defined disorder—Lamivudine—hepatitis B	0.00291	0.00312	CcSEcCtD
Nefazodone—Anaemia—Lamivudine—hepatitis B	0.0029	0.00311	CcSEcCtD
Nefazodone—Vomiting—Telbivudine—hepatitis B	0.00289	0.0031	CcSEcCtD
Nefazodone—Angioedema—Lamivudine—hepatitis B	0.00287	0.00307	CcSEcCtD
Nefazodone—Rash—Telbivudine—hepatitis B	0.00286	0.00307	CcSEcCtD
Nefazodone—Dermatitis—Telbivudine—hepatitis B	0.00286	0.00307	CcSEcCtD
Nefazodone—Headache—Telbivudine—hepatitis B	0.00284	0.00305	CcSEcCtD
Nefazodone—Malaise—Lamivudine—hepatitis B	0.00283	0.00303	CcSEcCtD
Nefazodone—Vertigo—Lamivudine—hepatitis B	0.00282	0.00302	CcSEcCtD
Nefazodone—Syncope—Lamivudine—hepatitis B	0.00281	0.00302	CcSEcCtD
Nefazodone—Leukopenia—Lamivudine—hepatitis B	0.00281	0.00301	CcSEcCtD
Nefazodone—HTR1A—blood plasma—hepatitis B	0.00281	0.101	CbGeAlD
Nefazodone—Loss of consciousness—Lamivudine—hepatitis B	0.00276	0.00296	CcSEcCtD
Nefazodone—Cough—Lamivudine—hepatitis B	0.00274	0.00294	CcSEcCtD
Nefazodone—Convulsion—Lamivudine—hepatitis B	0.00272	0.00292	CcSEcCtD
Nefazodone—Nausea—Telbivudine—hepatitis B	0.0027	0.00289	CcSEcCtD
Nefazodone—Arthralgia—Lamivudine—hepatitis B	0.00267	0.00286	CcSEcCtD
Nefazodone—Chest pain—Lamivudine—hepatitis B	0.00267	0.00286	CcSEcCtD
Nefazodone—Myalgia—Lamivudine—hepatitis B	0.00267	0.00286	CcSEcCtD
Nefazodone—Anxiety—Lamivudine—hepatitis B	0.00266	0.00285	CcSEcCtD
Nefazodone—Discomfort—Lamivudine—hepatitis B	0.00264	0.00283	CcSEcCtD
Nefazodone—Dry mouth—Lamivudine—hepatitis B	0.00261	0.0028	CcSEcCtD
Nefazodone—Confusional state—Lamivudine—hepatitis B	0.00258	0.00277	CcSEcCtD
Nefazodone—Anaphylactic shock—Lamivudine—hepatitis B	0.00256	0.00275	CcSEcCtD
Nefazodone—Oedema—Lamivudine—hepatitis B	0.00256	0.00275	CcSEcCtD
Nefazodone—Infection—Lamivudine—hepatitis B	0.00254	0.00273	CcSEcCtD
Nefazodone—Shock—Lamivudine—hepatitis B	0.00252	0.0027	CcSEcCtD
Nefazodone—Thrombocytopenia—Lamivudine—hepatitis B	0.00251	0.00269	CcSEcCtD
Nefazodone—Hyperhidrosis—Lamivudine—hepatitis B	0.00247	0.00265	CcSEcCtD
Nefazodone—Anorexia—Lamivudine—hepatitis B	0.00244	0.00262	CcSEcCtD
Nefazodone—Hypotension—Lamivudine—hepatitis B	0.00239	0.00257	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00233	0.0025	CcSEcCtD
Nefazodone—Insomnia—Lamivudine—hepatitis B	0.00231	0.00248	CcSEcCtD
Nefazodone—Paraesthesia—Lamivudine—hepatitis B	0.0023	0.00247	CcSEcCtD
Nefazodone—Dyspnoea—Lamivudine—hepatitis B	0.00228	0.00245	CcSEcCtD
Nefazodone—Somnolence—Lamivudine—hepatitis B	0.00228	0.00244	CcSEcCtD
Nefazodone—Dyspepsia—Lamivudine—hepatitis B	0.00225	0.00242	CcSEcCtD
Nefazodone—Decreased appetite—Lamivudine—hepatitis B	0.00222	0.00239	CcSEcCtD
Nefazodone—Pain—Lamivudine—hepatitis B	0.00219	0.00235	CcSEcCtD
Nefazodone—Constipation—Lamivudine—hepatitis B	0.00219	0.00235	CcSEcCtD
Nefazodone—Feeling abnormal—Lamivudine—hepatitis B	0.00211	0.00226	CcSEcCtD
Nefazodone—Gastrointestinal pain—Lamivudine—hepatitis B	0.00209	0.00225	CcSEcCtD
Nefazodone—CYP3A5—blood plasma—hepatitis B	0.00206	0.0746	CbGeAlD
Nefazodone—Urticaria—Lamivudine—hepatitis B	0.00203	0.00218	CcSEcCtD
Nefazodone—Abdominal pain—Lamivudine—hepatitis B	0.00202	0.00217	CcSEcCtD
Nefazodone—Body temperature increased—Lamivudine—hepatitis B	0.00202	0.00217	CcSEcCtD
Nefazodone—ADRA2A—blood plasma—hepatitis B	0.00197	0.0711	CbGeAlD
Nefazodone—Hypersensitivity—Lamivudine—hepatitis B	0.00189	0.00202	CcSEcCtD
Nefazodone—Asthenia—Lamivudine—hepatitis B	0.00184	0.00197	CcSEcCtD
Nefazodone—Pruritus—Lamivudine—hepatitis B	0.00181	0.00194	CcSEcCtD
Nefazodone—Diarrhoea—Lamivudine—hepatitis B	0.00175	0.00188	CcSEcCtD
Nefazodone—Dizziness—Lamivudine—hepatitis B	0.00169	0.00182	CcSEcCtD
Nefazodone—CYP3A7—liver—hepatitis B	0.00168	0.0607	CbGeAlD
Nefazodone—HTR2A—blood plasma—hepatitis B	0.00167	0.0605	CbGeAlD
Nefazodone—Vomiting—Lamivudine—hepatitis B	0.00163	0.00175	CcSEcCtD
Nefazodone—Rash—Lamivudine—hepatitis B	0.00161	0.00173	CcSEcCtD
Nefazodone—Dermatitis—Lamivudine—hepatitis B	0.00161	0.00173	CcSEcCtD
Nefazodone—Headache—Lamivudine—hepatitis B	0.0016	0.00172	CcSEcCtD
Nefazodone—CYP3A4—blood plasma—hepatitis B	0.00155	0.056	CbGeAlD
Nefazodone—CYP2D6—blood plasma—hepatitis B	0.00152	0.0551	CbGeAlD
Nefazodone—Nausea—Lamivudine—hepatitis B	0.00152	0.00163	CcSEcCtD
Nefazodone—CYP3A7-CYP3A51P—liver—hepatitis B	0.00143	0.0516	CbGeAlD
Nefazodone—SLC6A4—blood—hepatitis B	0.00116	0.0419	CbGeAlD
Nefazodone—ABCB1—blood plasma—hepatitis B	0.0011	0.0396	CbGeAlD
Nefazodone—ADRA1A—blood—hepatitis B	0.000947	0.0343	CbGeAlD
Nefazodone—CYP3A5—blood—hepatitis B	0.000756	0.0273	CbGeAlD
Nefazodone—ADRA1A—liver—hepatitis B	0.000741	0.0268	CbGeAlD
Nefazodone—ADRA2A—blood—hepatitis B	0.00072	0.026	CbGeAlD
Nefazodone—HTR2A—blood—hepatitis B	0.000613	0.0221	CbGeAlD
Nefazodone—CYP3A5—liver—hepatitis B	0.000591	0.0214	CbGeAlD
Nefazodone—CYP3A4—blood—hepatitis B	0.000567	0.0205	CbGeAlD
Nefazodone—CYP2D6—blood—hepatitis B	0.000558	0.0202	CbGeAlD
Nefazodone—HTR2A—liver—hepatitis B	0.000479	0.0173	CbGeAlD
Nefazodone—CYP3A4—liver—hepatitis B	0.000443	0.016	CbGeAlD
Nefazodone—CYP2D6—liver—hepatitis B	0.000436	0.0158	CbGeAlD
Nefazodone—ABCB1—blood—hepatitis B	0.000401	0.0145	CbGeAlD
Nefazodone—ABCB1—liver—hepatitis B	0.000314	0.0113	CbGeAlD
Nefazodone—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	6.93e-05	0.00172	CbGpPWpGaD
Nefazodone—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	6.86e-05	0.0017	CbGpPWpGaD
Nefazodone—SLC6A3—NRF2 pathway—TGFB1—hepatitis B	6.78e-05	0.00168	CbGpPWpGaD
Nefazodone—SLC6A3—SLC-mediated transmembrane transport—ALB—hepatitis B	6.75e-05	0.00167	CbGpPWpGaD
Nefazodone—ADRA2A—Platelet activation, signaling and aggregation—F2—hepatitis B	6.66e-05	0.00165	CbGpPWpGaD
Nefazodone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	6.46e-05	0.0016	CbGpPWpGaD
Nefazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	6.41e-05	0.00159	CbGpPWpGaD
Nefazodone—HTR2C—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	6.38e-05	0.00158	CbGpPWpGaD
Nefazodone—SLC6A4—SIDS Susceptibility Pathways—IL6—hepatitis B	6.36e-05	0.00158	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—HSPA5—hepatitis B	6.35e-05	0.00157	CbGpPWpGaD
Nefazodone—HTR2A—GPCR ligand binding—CXCL10—hepatitis B	6.34e-05	0.00157	CbGpPWpGaD
Nefazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	6.32e-05	0.00157	CbGpPWpGaD
Nefazodone—HTR2A—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	6.29e-05	0.00156	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—CXCL10—hepatitis B	6.21e-05	0.00154	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	6.2e-05	0.00154	CbGpPWpGaD
Nefazodone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	6.11e-05	0.00151	CbGpPWpGaD
Nefazodone—HTR2A—SIDS Susceptibility Pathways—NFKB1—hepatitis B	6.1e-05	0.00151	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—AKR1B1—hepatitis B	6.07e-05	0.00151	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	5.98e-05	0.00148	CbGpPWpGaD
Nefazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	5.87e-05	0.00146	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—GGT2—hepatitis B	5.82e-05	0.00144	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—CXCL10—hepatitis B	5.77e-05	0.00143	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—IFNB1—hepatitis B	5.73e-05	0.00142	CbGpPWpGaD
Nefazodone—HTR1A—GPCR ligand binding—CCR5—hepatitis B	5.69e-05	0.00141	CbGpPWpGaD
Nefazodone—SLC6A4—Circadian rythm related genes—TP53—hepatitis B	5.67e-05	0.00141	CbGpPWpGaD
Nefazodone—HTR2C—GPCR ligand binding—CCR5—hepatitis B	5.66e-05	0.0014	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SAG—hepatitis B	5.64e-05	0.0014	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—RIT2—hepatitis B	5.64e-05	0.0014	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—RIT2—hepatitis B	5.61e-05	0.00139	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SAG—hepatitis B	5.61e-05	0.00139	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—IFNA1—hepatitis B	5.59e-05	0.00139	CbGpPWpGaD
Nefazodone—HTR2A—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	5.54e-05	0.00137	CbGpPWpGaD
Nefazodone—ADRA2A—Platelet activation, signaling and aggregation—ALB—hepatitis B	5.53e-05	0.00137	CbGpPWpGaD
Nefazodone—ABCB1—Allograft Rejection—TGFB1—hepatitis B	5.51e-05	0.00137	CbGpPWpGaD
Nefazodone—HTR1A—SIDS Susceptibility Pathways—TNF—hepatitis B	5.49e-05	0.00136	CbGpPWpGaD
Nefazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	5.42e-05	0.00134	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR ligand binding—CCR5—hepatitis B	5.42e-05	0.00134	CbGpPWpGaD
Nefazodone—CYP3A4—Biological oxidations—GGT1—hepatitis B	5.41e-05	0.00134	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—RIT2—hepatitis B	5.37e-05	0.00133	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SAG—hepatitis B	5.37e-05	0.00133	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—IFNA2—hepatitis B	5.2e-05	0.00129	CbGpPWpGaD
Nefazodone—SLC6A4—Circadian rythm related genes—IL6—hepatitis B	5.19e-05	0.00129	CbGpPWpGaD
Nefazodone—ABCB1—Allograft Rejection—TNF—hepatitis B	5.14e-05	0.00127	CbGpPWpGaD
Nefazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	5.04e-05	0.00125	CbGpPWpGaD
Nefazodone—HTR2A—GPCR ligand binding—CCR5—hepatitis B	4.92e-05	0.00122	CbGpPWpGaD
Nefazodone—HTR1A—GPCR ligand binding—F2—hepatitis B	4.88e-05	0.00121	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SAG—hepatitis B	4.87e-05	0.00121	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—RIT2—hepatitis B	4.87e-05	0.00121	CbGpPWpGaD
Nefazodone—HTR2C—GPCR ligand binding—F2—hepatitis B	4.86e-05	0.0012	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—CCR5—hepatitis B	4.81e-05	0.00119	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—AKR1B1—hepatitis B	4.79e-05	0.00119	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SAG—hepatitis B	4.77e-05	0.00118	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—RIT2—hepatitis B	4.77e-05	0.00118	CbGpPWpGaD
Nefazodone—HTR2A—SIDS Susceptibility Pathways—TNF—hepatitis B	4.74e-05	0.00118	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR ligand binding—F2—hepatitis B	4.65e-05	0.00115	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GGT2—hepatitis B	4.59e-05	0.00114	CbGpPWpGaD
Nefazodone—ADRA2A—Platelet activation, signaling and aggregation—IL2—hepatitis B	4.48e-05	0.00111	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—CCR5—hepatitis B	4.47e-05	0.00111	CbGpPWpGaD
Nefazodone—HTR1A—SIDS Susceptibility Pathways—IL6—hepatitis B	4.43e-05	0.0011	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—RIT2—hepatitis B	4.43e-05	0.0011	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SAG—hepatitis B	4.43e-05	0.0011	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—AKR1B1—hepatitis B	4.39e-05	0.00109	CbGpPWpGaD
Nefazodone—HTR2A—GPCR ligand binding—F2—hepatitis B	4.22e-05	0.00105	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GGT2—hepatitis B	4.21e-05	0.00104	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—CXCL10—hepatitis B	4.15e-05	0.00103	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—F2—hepatitis B	4.13e-05	0.00102	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—CXCL10—hepatitis B	4.13e-05	0.00102	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—CXCL10—hepatitis B	3.95e-05	0.000979	CbGpPWpGaD
Nefazodone—SLC6A2—Transmembrane transport of small molecules—ALB—hepatitis B	3.87e-05	0.00096	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—F2—hepatitis B	3.84e-05	0.000951	CbGpPWpGaD
Nefazodone—HTR2A—SIDS Susceptibility Pathways—IL6—hepatitis B	3.83e-05	0.000949	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—CXCL10—hepatitis B	3.77e-05	0.000934	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CXCL10—hepatitis B	3.75e-05	0.000929	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CXCL10—hepatitis B	3.59e-05	0.000889	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CXCL10—hepatitis B	3.58e-05	0.000888	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—CYP2A6—hepatitis B	3.53e-05	0.000875	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CXCL10—hepatitis B	3.51e-05	0.00087	CbGpPWpGaD
Nefazodone—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	3.5e-05	0.000867	CbGpPWpGaD
Nefazodone—SLC6A3—Transmembrane transport of small molecules—ALB—hepatitis B	3.43e-05	0.000851	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—F2—hepatitis B	3.43e-05	0.000851	CbGpPWpGaD
Nefazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	3.41e-05	0.000845	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—NOS2—hepatitis B	3.39e-05	0.000841	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	3.36e-05	0.000834	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—AKR1B1—hepatitis B	3.31e-05	0.000821	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	3.29e-05	0.000815	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	3.28e-05	0.000813	CbGpPWpGaD
Nefazodone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	3.26e-05	0.000809	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	3.26e-05	0.000809	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CXCL10—hepatitis B	3.26e-05	0.000808	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CXCL10—hepatitis B	3.25e-05	0.000807	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—CCR5—hepatitis B	3.22e-05	0.000797	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—CCR5—hepatitis B	3.2e-05	0.000793	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—GOT2—hepatitis B	3.19e-05	0.000791	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CXCL10—hepatitis B	3.19e-05	0.00079	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GGT2—hepatitis B	3.18e-05	0.000787	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—AKR1B1—hepatitis B	3.12e-05	0.000774	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—CCR5—hepatitis B	3.06e-05	0.000759	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GGT2—hepatitis B	2.99e-05	0.000742	CbGpPWpGaD
Nefazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	2.96e-05	0.000734	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CXCL10—hepatitis B	2.96e-05	0.000734	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—CCR5—hepatitis B	2.92e-05	0.000724	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CCR5—hepatitis B	2.91e-05	0.00072	CbGpPWpGaD
Nefazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	2.9e-05	0.000719	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—ALB—hepatitis B	2.85e-05	0.000707	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CYP2A6—hepatitis B	2.78e-05	0.00069	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CCR5—hepatitis B	2.78e-05	0.00069	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CCR5—hepatitis B	2.78e-05	0.000689	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—F2—hepatitis B	2.76e-05	0.000684	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—GOT1—hepatitis B	2.75e-05	0.000683	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—GGT1—hepatitis B	2.75e-05	0.000683	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—F2—hepatitis B	2.75e-05	0.000681	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CCR5—hepatitis B	2.72e-05	0.000674	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	2.72e-05	0.000674	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—F2—hepatitis B	2.63e-05	0.000651	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CYP2A6—hepatitis B	2.55e-05	0.000632	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	2.54e-05	0.000629	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CCR5—hepatitis B	2.53e-05	0.000627	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CCR5—hepatitis B	2.52e-05	0.000625	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GOT2—hepatitis B	2.52e-05	0.000624	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—F2—hepatitis B	2.51e-05	0.000621	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—F2—hepatitis B	2.49e-05	0.000618	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CCR5—hepatitis B	2.47e-05	0.000612	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—F2—hepatitis B	2.39e-05	0.000592	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—F2—hepatitis B	2.38e-05	0.000591	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—F2—hepatitis B	2.33e-05	0.000579	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—IL2—hepatitis B	2.31e-05	0.000573	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GOT2—hepatitis B	2.31e-05	0.000572	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCR5—hepatitis B	2.3e-05	0.000569	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2.24e-05	0.000555	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CXCL10—hepatitis B	2.22e-05	0.000552	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CXCL10—hepatitis B	2.21e-05	0.000549	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GGT1—hepatitis B	2.17e-05	0.000539	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GOT1—hepatitis B	2.17e-05	0.000539	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—F2—hepatitis B	2.17e-05	0.000538	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—F2—hepatitis B	2.16e-05	0.000537	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—F2—hepatitis B	2.12e-05	0.000525	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CXCL10—hepatitis B	2.12e-05	0.000525	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—AKR1B1—hepatitis B	2.04e-05	0.000506	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GGT1—hepatitis B	1.99e-05	0.000494	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GOT1—hepatitis B	1.99e-05	0.000494	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—F2—hepatitis B	1.97e-05	0.000488	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GGT2—hepatitis B	1.96e-05	0.000485	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CYP2A6—hepatitis B	1.92e-05	0.000477	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CXCL10—hepatitis B	1.92e-05	0.000476	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CXCL10—hepatitis B	1.88e-05	0.000467	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—IL2—hepatitis B	1.86e-05	0.000461	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—IL2—hepatitis B	1.85e-05	0.000458	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CYP2A6—hepatitis B	1.81e-05	0.00045	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TGFB1—hepatitis B	1.8e-05	0.000447	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—IL2—hepatitis B	1.77e-05	0.000439	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCL10—hepatitis B	1.75e-05	0.000433	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GOT2—hepatitis B	1.74e-05	0.000431	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCR5—hepatitis B	1.73e-05	0.000428	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCR5—hepatitis B	1.72e-05	0.000426	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	1.71e-05	0.000423	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL2—hepatitis B	1.69e-05	0.000418	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL2—hepatitis B	1.68e-05	0.000416	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCR5—hepatitis B	1.64e-05	0.000407	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GOT2—hepatitis B	1.64e-05	0.000407	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL2—hepatitis B	1.61e-05	0.000398	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—IL2—hepatitis B	1.61e-05	0.000398	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—IL2—hepatitis B	1.57e-05	0.00039	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GOT1—hepatitis B	1.5e-05	0.000372	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GGT1—hepatitis B	1.5e-05	0.000372	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCR5—hepatitis B	1.49e-05	0.00037	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TP53—hepatitis B	1.48e-05	0.000368	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—F2—hepatitis B	1.48e-05	0.000367	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—F2—hepatitis B	1.47e-05	0.000365	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ALB—hepatitis B	1.46e-05	0.000363	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—IL2—hepatitis B	1.46e-05	0.000362	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCR5—hepatitis B	1.46e-05	0.000362	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL2—hepatitis B	1.46e-05	0.000361	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL2—hepatitis B	1.43e-05	0.000354	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GOT1—hepatitis B	1.42e-05	0.000351	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GGT1—hepatitis B	1.42e-05	0.000351	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—F2—hepatitis B	1.41e-05	0.000349	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCR5—hepatitis B	1.36e-05	0.000336	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL2—hepatitis B	1.33e-05	0.000329	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—F2—hepatitis B	1.28e-05	0.000317	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—F2—hepatitis B	1.25e-05	0.00031	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.19e-05	0.000294	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—F2—hepatitis B	1.16e-05	0.000288	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ALB—hepatitis B	1.16e-05	0.000286	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTEN—hepatitis B	1.12e-05	0.000277	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GOT2—hepatitis B	1.07e-05	0.000266	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ALB—hepatitis B	1.06e-05	0.000263	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2—hepatitis B	9.97e-06	0.000247	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL6—hepatitis B	9.92e-06	0.000246	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2—hepatitis B	9.92e-06	0.000246	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL6—hepatitis B	9.87e-06	0.000245	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CTNNB1—hepatitis B	9.62e-06	0.000239	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CTNNB1—hepatitis B	9.57e-06	0.000237	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2—hepatitis B	9.49e-06	0.000235	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL6—hepatitis B	9.45e-06	0.000234	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CDKN1A—hepatitis B	9.4e-06	0.000233	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PTEN—hepatitis B	9.38e-06	0.000233	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CDKN1A—hepatitis B	9.35e-06	0.000232	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NFKB1—hepatitis B	9.33e-06	0.000231	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PTEN—hepatitis B	9.33e-06	0.000231	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NFKB1—hepatitis B	9.29e-06	0.00023	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GGT1—hepatitis B	9.26e-06	0.000229	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GOT1—hepatitis B	9.26e-06	0.000229	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CTNNB1—hepatitis B	9.16e-06	0.000227	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CDKN1A—hepatitis B	8.95e-06	0.000222	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PTEN—hepatitis B	8.93e-06	0.000221	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NFKB1—hepatitis B	8.89e-06	0.00022	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTEN—hepatitis B	8.82e-06	0.000219	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2—hepatitis B	8.61e-06	0.000213	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6—hepatitis B	8.57e-06	0.000212	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2—hepatitis B	8.43e-06	0.000209	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6—hepatitis B	8.39e-06	0.000208	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CTNNB1—hepatitis B	8.31e-06	0.000206	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CTNNB1—hepatitis B	8.14e-06	0.000202	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CDKN1A—hepatitis B	8.12e-06	0.000201	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PTEN—hepatitis B	8.1e-06	0.000201	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTEN—hepatitis B	8.08e-06	0.0002	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NFKB1—hepatitis B	8.06e-06	0.0002	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALB—hepatitis B	7.99e-06	0.000198	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CDKN1A—hepatitis B	7.95e-06	0.000197	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PTEN—hepatitis B	7.93e-06	0.000197	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NFKB1—hepatitis B	7.9e-06	0.000196	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2—hepatitis B	7.84e-06	0.000194	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6—hepatitis B	7.8e-06	0.000193	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TGFB1—hepatitis B	7.78e-06	0.000193	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TGFB1—hepatitis B	7.74e-06	0.000192	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CTNNB1—hepatitis B	7.56e-06	0.000188	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALB—hepatitis B	7.53e-06	0.000187	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TGFB1—hepatitis B	7.41e-06	0.000184	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CDKN1A—hepatitis B	7.39e-06	0.000183	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PTEN—hepatitis B	7.37e-06	0.000183	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NFKB1—hepatitis B	7.34e-06	0.000182	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TGFB1—hepatitis B	6.72e-06	0.000167	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TGFB1—hepatitis B	6.58e-06	0.000163	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TP53—hepatitis B	6.4e-06	0.000159	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TP53—hepatitis B	6.37e-06	0.000158	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TGFB1—hepatitis B	6.11e-06	0.000152	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTEN—hepatitis B	6.1e-06	0.000151	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TP53—hepatitis B	6.1e-06	0.000151	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6—hepatitis B	5.86e-06	0.000145	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6—hepatitis B	5.83e-06	0.000145	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTEN—hepatitis B	5.75e-06	0.000142	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6—hepatitis B	5.58e-06	0.000138	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TP53—hepatitis B	5.53e-06	0.000137	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TP53—hepatitis B	5.42e-06	0.000134	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6—hepatitis B	5.06e-06	0.000125	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TP53—hepatitis B	5.03e-06	0.000125	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6—hepatitis B	4.96e-06	0.000123	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALB—hepatitis B	4.92e-06	0.000122	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6—hepatitis B	4.61e-06	0.000114	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTEN—hepatitis B	3.76e-06	9.31e-05	CbGpPWpGaD
